Enzymatica AB (publ) (STO:ENZY)
Sweden · Delayed Price · Currency is SEK 2.580
+0.080 (3.20%)
May 6, 2026, 5:29 PM CET
Enzymatica AB Market Cap
Enzymatica AB has a market cap or net worth of 606.84 million as of May 6, 2026. Its market cap has decreased by -23.08% in one year.
Market Cap
606.84M
Enterprise Value
581.44M
Revenue
53.06M
Ranking
n/a
PE Ratio
n/a
Stock Price
2.58
Market Cap Chart
Since June 14, 2011, Enzymatica AB's market cap has increased from 108.93M to 606.84M, an increase of 457.10%. That is a compound annual growth rate of 12.21%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| May 6, 2026 | 626.26M | 35.79% |
| Dec 30, 2025 | 461.20M | 35.28% |
| Dec 30, 2024 | 340.92M | -47.39% |
| Dec 29, 2023 | 647.99M | -12.33% |
| Dec 30, 2022 | 739.16M | -43.36% |
| Dec 30, 2021 | 1.31B | -51.13% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| BioGaia AB | 12.09B |
| Cereno Scientific AB | 1.84B |
| EQL Pharma AB | 1.41B |
| Orexo AB | 649.54M |
| Nanexa AB | 588.39M |
| Dicot Pharma AB | 568.64M |
| Cinclus Pharma Holding AB | 548.22M |
| Moberg Pharma AB | 512.31M |